Phoenix Biotech Acquisition (PBAX) - 2022 Q3 - Quarterly Report

FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Table of Contents 2201 Broadway, Suite 705, Oakland, CA 94612 (Address of Principal Executive Offices, including zip code) (215) 731-9450 (Registrant's telephone number, including area code) N/A For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O ...